Lensen R P, Rosendaal F R, Koster T, Allaart C F, de Ronde H, Vandenbroucke J P, Reitsma P H, Bertina R M
Department of Clinical Epidemiology, University Hospital Leiden, The Netherlands.
Blood. 1996 Dec 1;88(11):4205-8.
Both activated protein C (APC) resistance and protein C deficiency are associated with an increased risk for venous thrombosis. To assess their tendencies to venous thrombosis, we compared the median age of first venous thromboembolism in patients with factor V Leiden or protein C deficiency, who were identified either within unselected consecutive cases with a first deep venous thrombosis derived from a population-based case-control study, or identified by selection of patients with a deep venous thrombosis, who were referred for thrombophilIa work-up. The median age of onset for 92 unselected APC resistant cases was 43 years and for 13 unselected protein C-deficient cases 47 years. The median age at the first thrombotic event for 28 APC-resistant members of thrombophilia families was 29 years and for 50 protein C-deficient members of thrombophilia families 31.5 years. The median age of onset for all unselected patients (n = 105) was 45 years of age (range, 16 to 69 years) and the median age of onset for all selected patients from the thrombophilia families (n = 78) was 30.5 years (range, 16 to 67 years). These results show that within the case-control study and the family studies, the median age of onset is very similar in patients with APC resistance and patients with protein C deficiency. This suggests that APC resistance is not less severe with respect to risk of thrombosis than (heterozygous) protein C deficiency. In conclusion, the median age at which the first thrombosis occurs mainly depends on the way the patients are identified and not on the type of thrombophilia.
活化蛋白C(APC)抵抗和蛋白C缺乏均与静脉血栓形成风险增加相关。为评估它们引发静脉血栓形成的倾向,我们比较了因子V莱顿突变或蛋白C缺乏患者首次发生静脉血栓栓塞的中位年龄。这些患者是在一项基于人群的病例对照研究中连续纳入的、未经过筛选的首发深静脉血栓形成病例中确定的,或者是通过选择因血栓形成倾向检查而转诊的深静脉血栓形成患者确定的。92例未经筛选的APC抵抗患者的发病中位年龄为43岁,13例未经筛选的蛋白C缺乏患者为47岁。血栓形成倾向家族中28例APC抵抗成员首次血栓形成事件的中位年龄为29岁,50例蛋白C缺乏成员为31.5岁。所有未经筛选患者(n = 105)的发病中位年龄为45岁(范围16至69岁),血栓形成倾向家族中所有经筛选患者(n = 78)的发病中位年龄为30.5岁(范围16至67岁)。这些结果表明,在病例对照研究和家族研究中,APC抵抗患者和蛋白C缺乏患者的发病中位年龄非常相似。这表明就血栓形成风险而言,APC抵抗并不比(杂合子)蛋白C缺乏轻。总之,首次血栓形成发生的中位年龄主要取决于患者的确定方式,而非血栓形成倾向的类型。